Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News TherapeuticsMD Inc TXMD

Healthcare Drug Manufacturers - Specialty & Generic
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors... see more

Current News (NDAQ:TXMD)

TherapeuticsMD Announces Third Quarter 2025 Financial Results

Business Wire November 12, 2025

TherapeuticsMD Announces Second Quarter 2025 Financial Results

Business Wire August 12, 2025

TherapeuticsMD Announces First Quarter 2025 Financial Results

Business Wire May 13, 2025

TherapeuticsMD Announces Full Year 2024 Financial Results

Business Wire March 27, 2025

TherapeuticsMD Announces Third Quarter 2024 Financial Results

Business Wire November 12, 2024

TherapeuticsMD Announces Second Quarter 2024 Financial Results

Business Wire August 12, 2024

TherapeuticsMD Announces First Quarter 2024 Financial Results

Business Wire May 10, 2024

TherapeuticsMD Announces Full Year 2023 Financial Results

Business Wire March 29, 2024

TherapeuticsMD Announces Third Quarter 2023 Financial Results

Business Wire November 14, 2023
View More News ››

Opinion & Analysis (NDAQ:TXMD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TXMD)

TherapeuticsMD, Inc. (NASDAQ:TXMD): A Pharmaceutical Royalty

http://beyondspx.com/2024/08/01/therapeuticsmd-inc-nasdaqtxmd-a-pharmaceutical-royalty-company-navigating-a-transformative-transition/
MikeTester - August 2, 2024

$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀

iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver...
Saaaa1 - May 6, 2021

news comings

gl all
Cgbuddy - January 22, 2021

welcome all im new here

gl all
Cgbuddy - January 21, 2021

RE:added more of this one

You still accumulating this one ? I like what I see - thoughts ?
MrMugsy - December 22, 2020

added more of this one

using DCA,dollar cost averaging,so glta shareholders.
coolfooldumbguy - February 11, 2020
View more Bullboard ››

dynaCERT Inc.

dynaCERT Inc.

dynaCERT Inc., together with its subsidiaries, engages in the design, engineering, manufacture, testing, and distribution of ...
View More »

Podcasts